Related Experiment Video
Updated: Jun 24, 2025
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Optimizing vancomycin dosing in pediatrics: a machine learning approach to predict trough concentrations in children
Minghui Yin1, Yuelian Jiang2, Yawen Yuan2
1School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200127, China.
Insights
Machine learning accurately predicts vancomycin trough concentrations in young children. The XGBoost model, using factors like kidney function, aids in optimizing pediatric vancomycin dosing for better efficacy and safety.
Area of Science:
- Pharmacometrics and Computational Biology
- Pediatric Pharmacology
- Machine Learning in Medicine
Background:
- Vancomycin trough concentration is critical for both efficacy and toxicity in pediatric patients.
- Predicting these concentrations is complex due to patient variability and developmental changes.
- Accurate prediction is essential for safe and effective vancomycin therapy in children.
Purpose of the Study:
- To develop and evaluate machine learning (ML) models for predicting vancomycin trough concentrations in pediatric patients under 4 years old.
- To identify optimal dosing regimens using ML algorithms.
- To enhance therapeutic drug monitoring strategies for vancomycin in this age group.
Main Methods:
- A retrospective observational study analyzed data from pediatric patients receiving intravenous vancomycin.
- Seven ML models, including XGBoost, were trained and tested using 31 patient variables.
- Model performance was assessed using R-squared, MSE, RMSE, and MAE, with feature importance analysis.
Main Results:
- The XGBoost model demonstrated superior performance in predicting vancomycin trough concentrations (R²=0.59, MAE=2.55, RMSE=4.13).
- Key predictors identified included blood urea nitrogen, serum creatinine, and creatinine clearance rate.
- The model effectively captured the variability in vancomycin levels within the pediatric cohort.
Conclusions:
- An XGBoost-based ML model can reliably predict vancomycin trough concentrations in pediatric patients.
- This model serves as a valuable decision-support tool for optimizing vancomycin dosing.
- The findings support the integration of ML into clinical practice for personalized pediatric pharmacotherapy.
Background:
Vancomycin trough concentration is closely associated with clinical efficacy and toxicity. Predicting vancomycin trough concentrations in pediatric patients is challenging due to significant inter-individual variability and rapid physiological changes during maturation.
Aim:
This study aimed to develop a machine learning model to predict vancomycin trough concentrations and determine optimal dosing regimens for pediatric patients < 4 years of age using ML algorithms.
Method:
A single-center retrospective observational study was conducted from January 2017 to March 2020. Pediatric patients who received intravenous vancomycin and underwent therapeutic drug monitoring were enrolled. Seven ML models [linear regression, gradient boosted decision trees, support vector machine, decision tree, random forest, Bagging, and extreme gradient boosting (XGBoost)] were developed using 31 variables. Performance metrics including R-squared (R2), mean square error (MSE), root mean square error (RMSE), and mean absolute error (MAE) were compared, and important features were ranked.
Results:
The study included 120 eligible trough concentration measurements from 112 patients. Of these, 84 measurements were used for training and 36 for testing. Among the seven algorithms tested, XGBoost showed the best performance, with a low prediction error and high goodness of fit (MAE = 2.55, RMSE = 4.13, MSE = 17.12, and R2 = 0.59). Blood urea nitrogen, serum creatinine, and creatinine clearance rate were identified as the most important predictors of vancomycin trough concentration.
Conclusion:
An XGBoost ML model was developed to predict vancomycin trough concentrations and aid in drug treatment predictions as a decision-support technology.
Related Concept Videos
01:15Two-Compartment Open Model: IV Infusion
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
01:19Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:25Clearance Models: Compartment Models
01:24One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
01:12Analysis of Population Pharmacokinetic Data